@article{vergnenegre:hal-04143449,
TITLE = {Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine--atezolizumab combination for stage-IV non-small-cell lung cancer -- VinMetAtezo trial, (GFPC^‡ 04-2017)},
AUTHOR = {Vergnenegre, Alain and Monnet, Isabelle and Bizieux, Acya and Bernardi, Marie and Chiapa, Anne Marie and L{\'e}na, Herv{\'e} and Choua{\"i}d, Christos and Robinet, Gilles},
URL = {https://hal.u-pec.fr/hal-04143449},
JOURNAL = {Future Oncology},
PUBLISHER = {Future Medicine},
VOLUME = {16},
NUMBER = {4},
PAGES = {5 - 10},
YEAR = {2020},
MONTH = Jan, DOI = {10.2217/fon-2019-0730},
KEYWORDS = {immunotherapy ; metronomic chemotherapy ; non-small-cell lung cancer ; second line},
PDF = {https://hal.u-pec.fr/hal-04143449/file/fon-2019-0730.pdf},
HAL_ID = {hal-04143449},
HAL_VERSION = {v1},
}